IRAK-1(Phospho Thr209) Polyclonal Antibody

This gene encodes the interleukin-1 receptor-associated kinase 1, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This gene is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

The IRAK-1(Phospho Thr209) Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of IRAK-1 protein phosphorylated at threonine 209. This antibody is produced using advanced polyclonal antibody technology, ensuring high affinity and specificity for the target protein.

The IRAK-1 protein plays a crucial role in the innate immune response by mediating the signaling pathway downstream of Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). Phosphorylation of IRAK-1 at threonine 209 is known to regulate its activity and function, making it an important target for research in immunology and inflammation.

This polyclonal antibody has been rigorously validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits excellent sensitivity and specificity, enabling accurate and reliable detection of phosphorylated IRAK-1 protein in various sample types.

The IRAK-1(Phospho Thr209) Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and concentration, ensuring cost-effectiveness and minimizing waste. The antibody is also available in different formats, allowing flexibility in experimental design and application.

With its exceptional performance and reliability, the IRAK-1(Phospho Thr209) Polyclonal Antibody is an indispensable tool for researchers studying the role of IRAK-1 phosphorylation in immune response and inflammation. Its high specificity and sensitivity make it an ideal choice for both basic research and drug development in the field of immunology.